Karinza Phoenix
Executive Chair & CEO, Myopharm
Axel Heiser is Chief Scientist and Principal Scientist for the AgResearch Group within the Bioeconomy Science Institute (BSI). After earning his PhD in Biology from the University of Kiel, Axel’s career has spanned research institutions in Germany, the USA, and New Zealand, including Otago University, Duke University, and the University of Florida. He is recognised for pioneering work in RNA-based vaccines, notably developing cancer vaccines using RNA-transfected dendritic cells. Since joining AgResearch in 2010, Axel’s research has focused on innovative approaches to vaccine development, diagnostics, and immune health, integrating immunology with nutrition, reproduction, and animal production. His current work centres on the development of RNA vaccines targeting livestock diseases.
Executive Chair & CEO, Myopharm
COO, Cadmus Animal Health
Principal, Athfield Architects
Founder & Managing Director, Amerging Technologies